Captrust Financial Advisors Vaxart, Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.29 - $6.64 $540 - $836	-126 Reduced 22.42%	436 $2,000
Q4 2021 Feb 14, 2022	BUY	$5.77 - $7.96 $3,138 - $4,330	544 Added 3022.22%	562 $4,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $10.78 $3,541 - $7,546	-700 Reduced 97.49%	18 $0
Q1 2021 May 17, 2021	SELL	$5.64 - $23.33 $9,588 - $39,661	-1,700 Reduced 70.31%	718 $4,000
Q4 2020 Feb 16, 2021	BUY	$3.5 - $7.98 $7,063 - $16,103	2,018 Added 504.5%	2,418 $14,000
Q2 2020 Aug 14, 2020	BUY	$1.68 - $8.85 $672 - $3,540	400 New	400 $3,000

108

37.9M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $93.6M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.